Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Show other versions (4)

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g. medication availability). This article summarizes key recommendations from GINA 2021,...

Full description

Bibliographic Details
Main Authors: Bacharier, L.B (Author), Bateman, E.D (Author), Boulet, L.-P (Author), Brightling, C.E (Author), Brusselle, G.G (Author), Buhl, R. (Author), Cruz, A.A (Author), Drazen, J.M (Author), Duijts, L. (Author), FitzGerald, J.M (Author), Fleming, L.J (Author), Inoue, H. (Author), Ko, F.W (Author), Krishnan, J.A (Author), Levy, M.L (Author), Lin, J. (Author), Mortimer, K. (Author), Pitrez, P.M (Author), Reddel, H.K (Author), Sheikh, A. (Author), Yorgancioglu, A.A (Author)
Format: Article
Language:English
Published: European Respiratory Society 2022
Subjects:
antiasthmatic agent
Anti-Asthmatic Agents
asthma
Asthma
human
Humans
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items